Universe Pharmaceuticals (UPC) Total Debt (2020 - 2024)
Historic Total Debt for Universe Pharmaceuticals (UPC) over the last 6 years, with Q3 2025 value amounting to $446.5 billion.
- Universe Pharmaceuticals' Total Debt fell 9505.93% to $446.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $446.5 billion, marking a year-over-year decrease of 9505.93%. This contributed to the annual value of $446.5 billion for FY2025, which is 9505.93% down from last year.
- Universe Pharmaceuticals' Total Debt amounted to $446.5 billion in Q3 2025, which was down 9505.93% from $9038.1 billion recorded in Q3 2024.
- Universe Pharmaceuticals' 5-year Total Debt high stood at $9038.1 billion for Q3 2024, and its period low was $7293.0 during Q1 2022.
- For the 5-year period, Universe Pharmaceuticals' Total Debt averaged around $1185.6 billion, with its median value being $5.5 million (2023).
- As far as peak fluctuations go, Universe Pharmaceuticals' Total Debt crashed by 10000.0% in 2021, and later skyrocketed by 16485424630.03% in 2024.
- Universe Pharmaceuticals' Total Debt (Quarter) stood at $19723.0 in 2021, then soared by 17033.62% to $3.4 million in 2022, then surged by 62.24% to $5.5 million in 2023, then soared by 164854246.3% to $9038.1 billion in 2024, then tumbled by 95.06% to $446.5 billion in 2025.
- Its Total Debt was $446.5 billion in Q3 2025, compared to $9038.1 billion in Q3 2024 and $7.6 million in Q1 2024.